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Abstract
Proteinuria is strongly associated with kidney disease progression but the mechanisms
underlying podocyte handling of serum proteins such as albumin and IgG remain to be eluci-
dated. We have previously shown that albumin and IgG are transcytosed by podocytes in
vitro. In other epithelial cells, the neonatal Fc receptor (FcRn) is required to salvage albumin
and IgG from the degradative pathway thereby allowing these proteins to be transcytosed or
recycled. Here we directly examine the role of FcRn in albumin and IgG trafficking in podo-
cytes by studying handling of these proteins in FcRn knockout (KO) podocytes in vitro and in
a podocyte-specific FcRn knockout mice in vivo. In vitro, we find that knockout of FcRn
leads to IgG accumulation in podocytes but does not alter albumin trafficking. Similarly, in
vivo, podocyte-specific knockout of FcRn does not result in albumin accumulation in podo-
cytes in vivo as measured by mean albumin fluorescence intensity whereas these mice
demonstrate significant intraglomerular accumulation of IgG over time. In addition we find
that podocyte-specific FcRn KO mice demonstrate mesangial expansion as they age and
activation of mesangial cells as demonstrated by increased expression of α-smooth muscle
actin. Taken together, these results suggest that trafficking pathways for albumin and IgG
differ in podocytes and that sustained disruption of trafficking of plasma proteins alters glo-
merular structure.
Introduction
Proteinuria is an independent marker of kidney disease progression and is widely used clini-
cally as a biomarker of kidney dysfunction [1, 2]. Proteinuria is both a consequence of kidney
damage and damages the glomerulus and tubules directly by increasing production of pro-
inflammatory cytokines and promoting fibrosis [1, 3–5]. Both the glomerulus and the proxi-
mal tubules are involved in the renal handling of serum proteins but the molecular
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mechanisms remain to be fully elucidated. The primary barrier to filtration of large plasma
proteins into the urine is the glomerular filtration barrier (GFB) which consists of three lay-
ers–a fenestrated endothelium, the glomerular basement membrane and the podocyte [6]. The
podocyte is a specialized epithelial cell containing a large cell body and multiple processes
which ramify to form smaller processes. Paracellular passage of large serum proteins is pre-
vented by the slit diaphragm which extends between the foot processes of neighboring podo-
cytes and precludes filtration of proteins ~ 70 kDa or larger. The precise amount of albumin
filtered through the GFB is a contested topic [7, 8]. By even the most conservative estimates, ~
4 g albumin a day transit the GFB [9]. The amount of IgG that traverses the glomerular filtra-
tion barrier is unknown.
Podocytes have been shown to take up albumin in vitro and in vivo [4, 10–12]. Using in
vitro assays, we have previously shown that podocytes endocytose albumin and that most is
transcytosed, with a smaller amount sent to the lysosome for degradation [13]. These findings
have been confirmed in vivo using intravital multiphoton microscopy in rats [11]. In other epi-
thelial cells, including those in the renal proximal tubule, the neonatal Fc receptor (FcRn) is
required to prevent albumin and IgG from entering the degradative pathway, thereby allowing
albumin to be recycled or transcytosed [14–17]. FcRn, has homology to major histocompati-
bility complex class I and binds albumin and IgG at pH 6–6.5 but has minimal affinity for
these proteins at neutral pH [18]. Within the adult kidney, FcRn is expressed in podocytes, vas-
cular endothelial cells and the proximal tubule [19]. The physiologic role of FcRn in albumin
trafficking in podocytes is unknown.
Akilesh et al. demonstrated that the neonatal Fc receptor is required to prevent the intraglo-
merular accumulation of IgG in mice [20]. These studies were performed in global FcRn
knockout (KO) mice which manifest hypoalbuminemia and hypogammaglobulinemia. Plasma
levels of albumin and IgG are 50% [17] and 80–90% [21] lower respectively in global FcRn KO
compared to wild type (WT) mice. Thus podocytes in the global KO are exposed to signifi-
cantly less albumin and IgG than WT mice which might alter trafficking pathways.
Here we use in vitro assays and podocyte-specific FcRn knockout mice to directly examine
the role of FcRn in albumin and IgG trafficking in podocytes. Creation of podocyte-specific
FcRn KO mice allowed for the examination of intraglomerular trafficking of albumin and IgG
in mice that have normal serum levels of these proteins, permitting direct assessment of FcRn
mediated trafficking of albumin and IgG in podocytes.
Materials and methods
Generation of conditionally immortalized WT and FcRn KO podocytes
Podocytes were isolated from wild type or global FcRn KO mice as previously described [22].
Primary podocytes were immortalized using a thermosensitive SV40 T antigen as previously
described [23]. Briefly, media containing viral particles was collected from the viral producer
line plpcx SVtsa58 (kindly provided by Dr. Parmjit Jat) and applied to primary WT or FcRn
KO podocytes. The plpcs SVtsa58 viral producer line encodes the thermolabile tsA58 LT anti-
gen and G418 resistance. Podocytes were selected using G418. After selection, podocytes were
allowed to replicate at 33˚C. To induce differentiation, podocytes were placed at 37˚C for 8–10
days. To verify expression of podocyte markers, podocytes were stained with podocin or WT1.
In vitro trafficking assay
The in vitro albumin and IgG trafficking experiments were performed as previously described
[13]. Briefly, WT or FcRn KO podocytes were loaded with 1.5 mg/ml FITC-human albumin or
1 mg/ml human IgG at 4˚C (which permits binding and inhibits endocytosis) or 37˚C (which
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permits endocytosis). Previous work has shown that mouse FcRn binds both human albumin
and IgG at the concentrations used in these studies [24]. After loading, cells were washed well
and incubated in Ringer solution (122.5 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl2, 0.8 mM
MgCl2, 0.8 mM Na2HPO4, 0.2 mM NaH2PO4, 5.5 mM glucose, and 10 mM HEPES; pH 7.4) at
4˚C or 37˚C in the presence or absence of 20 μM leupeptin (which inhibits lysosomal degrada-
tion). Cells and supernatant were either harvested immediately (t = 0) or at the designated
time points. The supernatant was removed by evaporation under a vacuum and the remaining
albumin or IgG resuspended in 35 μl RIPA buffer. The amount of albumin or IgG in the cellu-
lar or fraction was assessed by western blot analysis.
Western blotting
Podocytes were harvested by scraping into RIPA buffer and protein concentrations were mea-
sured using the BCA assay (Pierce, Thermofisher Scientific, Waltham, MA). Samples were
reduced using 10% β-mercaptoethanol. The Western blot procedure was performed as
described in detail in [13, 25]. Briefly, cell lysates were run on 10% polyacrylamide gels and
transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA). Subsequent blocking,
antibody, and wash solutions were diluted in PBS-T (phosphate-buffered saline, 1% Triton-X
100). Membranes were blocked in 5% nonfat dry milk in PBS-T for 60 minutes and then incu-
bated with primary antibody. The primary antibodies used were as follows: FITC (1:1,000;
clone ZF2471–1900, Invitrogen; Carlsbad, CA), IgG (1:1000; GW20083F, Sigma-Aldrich,
St. Louis, MO), actin (1:5,000; A1978, Sigma-Aldrich). Blots were washed and then incubated
with horseradish peroxidase-conjugated secondary antibodies (1:10,000 dilution; Jackson
ImmunoResearch, West Grove, PA). The antibody complexes were detected using enhanced
chemiluminescence (Pierce) and Western blot images were captured using a photodocumen-
tation system (UVP; Upland, CA).
PCR
Total RNA was isolated using RNeasy Mini Kit (QIAGEN, Valencia, CA). cDNA was synthe-
sized from total RNA (1 μg) with the High Capacity cDNA Reverse Transcriptase Kit (Invitro-
gen) which uses the random primer scheme. The primers used for FcRn are as follows: sense
50-TGA CCT GTG CTG CTT TCT CCT-30, antisense 50-CAG CAA TGA CCA TGC GTG
GAA-30. Real-time PCR was performed with the use of the AppIied Biosystems Step One Plus
Real-Time PCR System (Life Technologies, Carlsbad, CA). The expression of a target gene in
relation to a reference gene was calculated using a comparative cycle threshold (Ct) method.
Animals
Podocyte specific FcRn knockout mice were obtained by crossing FcRn floxed mice [26] (a
kind gift of Dr. Sally Ward, UT Southwestern) with podocin-Cre mice (Jackson Labs, Bar Har-
bor, Maine). Genotype was determined by PCR. All experimental mice were homozygous for
the floxed FcRn gene. Podocyte specific FcRn knockout mice (FcRn fl/fl;cre/+) were double
transgenic resulting in no FcRn expression in podocytes. Control mice (FcRn fl/fl;+/+) were
single transgenic (no Cre expression) resulting in unchanged FcRn expression in podocytes.
Male mice were used for all experiments. For the aging studies the number of mice is as fol-
lows: 3 month old control or podocyte specific FcRn knockout, n = 3 animals per group; 6
month old control or podocyte specific FcRn knockout, n = 6 animals per group; 12 month
old control or podocyte specific FcRn knockout, n = 6 animals per group. All procedures
involving animals were performed using protocols approved by the Institutional Animal Care
FcRn trafficking of albumin and IgG in the glomerulus
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and Use Committee at the University of Colorado, Denver, protocol number 00085. Animals
were euthanized using pentobarbital.
Urine albumin was measured using the Albuwell assay (Exocell), urine creatinine was mea-
sured using the assay and BUN was measured on an Alpha Wasserman auto analyzer. Serum
albumin was measured by ELISA (Abcam) as was serum IgG (Affymetrix).
For the GFR measurements, urine was collected by placing mice in metabolic cages for 24
hours. Serum and urine creatinine concentrations were analyzed with HPLC-MS/MS (Applied
Biosystems 3200 Qtrap). Creatinine and [2H3] creatinine were detected in multiple reaction
monitoring mode, monitoring the transitions of the m/z from 114 to 44.2 and from 117 to
47.2, respectively [27]. Mice were aged 9–12 months. Four male control and 3 podocyte-spe-
cific FcRn KO mice were used.
Immunofluorescence
Confocal microscopy images were acquired using Zeiss 780 laser-scanning confocal/multipho-
ton-excitation fluorescence microscope with a 34-Channel GaAsP QUASAR Detection Unit
and non-descanned detectors for two-photon fluorescence (Zeiss, Thornwood, NY). The
imaging settings were initially set to maximize the signal-to-noise ratio, avoid saturation and
ensure minimal contributions from tubular autoflluorescence. The settings were kept constant
between different samples. Images were obtained with a Zeiss C-Apochromat 40x/1.2NA Korr
FCS M27 water-immersion lens objective. The illumination for imaging was provided by a
30mW Argon Laser using excitation at 488 nm, HeNe 5mW (633 nm) and 1mW (543 nm).
Image processing was performed using Zeiss ZEN 2012 software. Images were analyzed in
Image J software (NIH, Bethesda, Maryland). Fluorescence intensity of albumin or IgG was
normalized to glomerular area. 20–25 glomeruli were analyzed per mouse.
Preparation of cells for fixed cell images was performed as described in detail in [13]. Podo-
cytes were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) with 0.5% Triton
X-100 (20 min; room temp), washed, blocked with 10% normal serum and labeled with pri-
mary antibodies. Primary antibodies were as follows: Podocin (1:200, P0372, Sigma-Aldrich),
WT-1 (1: 200, sc-192, Santa Cruz), FcRn (1: 100, sc-66892, Santa Cruz). Cells were subse-
quently washed and labeled with the appropriate conjugated secondary antibodies (Alexa
Fluor 488, Alexa Fluor 568; Invitrogen). F-actin was concurrently stained with Alexa-Phalloi-
din 633 (Invitrogen).
For the in vivo immunolocalization studies, the kidneys were cleared of blood by perfusion
of phosphate-buffered saline (PBS) and then fixed by perfusion with 4% paraformaldehyde
(Electron Microscopy Sciences; Hatfield, PA) in PBS (pH 7.4). The kidneys were then removed,
immersed in 4% paraformaldehyde for 24hr, infused with 5% (2 hr), 10% (2 hr) and 25% (over-
night) sucrose, frozen in liquid nitrogen and cryosectioned (3 μm). Kidney sections were
blocked (10% normal goat serum in PBS) and incubated overnight at 4˚C with primary anti-
body: IgG (1:250; GW20083F, Sigma-Aldrich), albumin (1:250; ab106582, Abcam, Cambridge,
UK), a-SMA (1:250; 1A4, Sigma-Aldrich). After washing, the sections were incubated (60 min,
room temperature) with appropriate mix of Alexa 488-conjugated goat anti-chicken IgG (1:500;
Invitrogen) and Alexa 633-conjugated phalloidin (1:200; Invitrogen). Sections were then
washed with PBS and mounted in Fluromount-G (Thermo Fisher Scientific, Waltham, MA).
Histology
3 μm sections were cut from paraffin embedded tissue and stained using the periodic acid
Schiff reagent. Analysis of glomerular and mesangial area was performed using NDP.view 2
(Hamamatsu, Hamamatsu City, Japan). 20–30 glomeruli were analyzed per mouse.
FcRn trafficking of albumin and IgG in the glomerulus
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Data analysis
Data are presented as means ± SE. Statistical analysis was performed using t-tests for two
groups and one-way analysis of variance for three or more groups, using Prism software
(GraphPad, San Diego, CA). Tukey’s post hoc test was applied to the ANOVA data. Values
were considered statistically significant when p< 0.05.
Results
Establishing WT and FcRn KO podocyte cell lines
In order to directly investigate the role of FcRn in albumin and IgG trafficking in podocytes,
we isolated podocytes from WT and global FcRn KO mice and created conditionally immor-
talized cell lines by transforming primary podocytes with the thermosensitive SV40 T antigen
[23]. Differentiated WT and FcRn KO podocytes expressed the podocyte markers podocin
and Wilms tumor 1 (WT1) (Fig 1A) and FcRn KO podocytes had minimal FcRn mRNA as
assessed by qPCR (Fig 1B). FcRn knockout did not impair albumin or IgG uptake in podocytes
(Fig 1C).
FcRn KO impairs IgG trafficking but not albumin trafficking in vitro
To examine IgG and albumin trafficking in vitro, differentiated WT and FcRn KO podocytes
were loaded with albumin or IgG at 4˚C (a temperature that allows surface binding of albumin
or IgG but inhibits endocytosis) or 37˚C (permits endocytosis), washed well after loading and
harvested immediately or at the times indicated in Fig 2. Leupeptin, a lysosomal enzyme inhib-
itor, was also used to examine the effects of blocking lysosomal degradation on albumin and
IgG trafficking in WT and FcRn KO podocytes. In WT podocytes loaded with IgG at 37˚C,
there was a decrease in the amount of IgG remaining in the cells after 30 minutes incubation
in Ringer solution (Fig 2A). Inhibition of lysosomal degradation with leupeptin did not signifi-
cantly increase the amount of IgG remaining in WT podocytes after 30 minutes incubation in
Ringer solution, suggesting that monomeric IgG is not trafficked to the lysosome. In contrast
to WT podocytes, the amount of IgG remaining intracellularly in FcRn KO podocytes 30 min-
utes after loading with IgG was not significantly decreased, suggesting impairment in IgG
transcytosis in the KO (Fig 2A).
Albumin trafficking in WT and FcRn KO podocytes was examined by loading podocytes
with FITC-labeled albumin, washing the podocytes very well and then assessing how much
FITC-albumin remained in the podocytes immediately after washing or after 60 minutes in
Ringer solution ± leupeptin to inhibit lysosomal degradation. Podocytes were assessed after 60
min as initial studies demonstrated that albumin is trafficked more slowly than IgG. As shown
in Fig 2B, in both WT and FcRn KO podocytes loaded with FITC-albumin at 37˚C there was a
significant decrease in the amount of albumin remaining in the cells 60 minutes after incuba-
tion in Ringer solution. Thus, knockout of FcRn did not impair albumin trafficking in podo-
cytes in vitro. In both WT and KO podocytes, there was a trend towards increased albumin
accumulation in leupeptin treated cells at t = 60 minutes, 37˚C but this was not significant.
Podocyte-specific FcRn KO mice
In order to determine whether the differential trafficking of albumin and IgG in podocytes
lacking FcRn occurred in vivo, we generated podocyte-specific FcRn KO (FcRn fl/fl;Podocin-
Cre/+) mice by crossing podocin-Cre mice with FcRn floxed mice (Fig 3). FcRn floxed mice
lacking the Cre transgene (FcRn fl/fl;+/+) served as littermate controls. FcRn fl/fl;Podocin-
Cre/+ mice had similar serum levels of albumin and IgG compared to controls (Fig 3A). There
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was no difference in the urinary albumin to creatinine ratio in podocyte-specific FcRn KO
mice versus control at 3, 6 and 12 months (Fig 3B). There was also no difference in estimated
glomerular filtration rate (eGFR) in 9–12 month control or podocyte specific FcRn KO mice
(Fig 3C).
Podocyte-specific KO of FcRn results in IgG accumulation in the
glomerulus
We used immunofluorescence staining to examine whether lack of FcRn in podocytes results
in albumin or IgG accumulation in the glomerulus as mice age. There was no significant differ-
ence in IgG accumulation in the glomeruli of podocyte-specific FcRn KO versus control mice
at 3 months of age (mean IgG fluorescence/glomerular area 3.9 ± 0.5 vs 5.1 ± 0.4, p = NS; Fig
4A). By 6 months of age, podocyte-specific FcRn KO mice had a significant increase in
Fig 1. Characterization of FcRn knockout podocytes. A, Conditionally immortalized wild type (WT) and FcRn knockout (KO) podocytes express the podocyte markers
podocin and Wilms Tumor 1 (WT1). Scale bar 20 μm. B, FcRn KO podocytes have minimal expression of FcRn mRNA. C, There was no significant differences in uptake
of FITC-albumin or IgG in wild type versus FcRn KO podocytes. n = 3 experiments.
https://doi.org/10.1371/journal.pone.0209732.g001
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glomerular IgG compared to controls (5.7 ± 0.3 vs 4.1 ± 0.2, p< 0.05). At 12 months of age
there was a statistically significant increase in the amount of IgG present in the glomerulus in
podocyte-specific FcRn KO compared to controls (9.4 ± 0.5 vs 5.6 ± 0.5, p< 0.0001).
Podocyte-specific KO of FcRn results in minimal intraglomerular albumin
accumulation
When mean albumin intensity per glomerulus was measured, there was no significant differ-
ence in albumin accumulation in the glomeruli of 3 month, 6 month or 12 month old versus
podocyte-specific FcRn KO versus control mice (Fig 4B). Interestingly, there was a significant
time dependent decrease in intraglomerular albumin accumulation with 12 month old control
and podocyte-specific FcRn KO mice exhibiting a significant decrease in albumin accumula-
tion within the glomerulus compared to the respective 3 month old mice (mean albumin fluo-
rescence/glomerular area for 12 month versus 3 month old mice 1.5 ± 0.1 vs 2.5 ± 0.1 for
controls, p< 0.0001 and 1.8 ± 0.1 vs 2.3 ± 0.1 for KO, p< 0.01). The lack of albumin detection
within the glomerulus was not due to an inability to stain for albumin as albumin within the
blood vessels surround the glomerulus was readily detected (Fig 4B).
The final concentration of albumin in the urine has been shown to be dependent on both
passage of albumin through the glomerular filtration barrier and proximal tubular uptake of
Fig 2. FcRn KO impaired albumin but not IgG transcytosis in podocytes in vitro. A, Cultured podocytes from FcRn KO mice demonstrate impaired IgG transcytosis.
There is significantly less monomeric IgG in the cellular fraction in WT podocytes 30 min after loading with IgG, whereas the amount of monomeric IgG in the cellular
fraction in KO podocytes is comparable to that at t = 0. Inhibition of lysosomal degradation does not alter the amount of monomeric IgG present in the cellular fraction
suggesting that IgG is not sent to the lysosome. �, p = 0.0017 compared to the same condition at t = 0; n = 10 experiments. Time (0, 30) is in minutes; L = leupeptin. B, In
contrast, FcRn KO has no effect on albumin transcytosis in cultured podocytes. There is significantly less albumin in the cellular fraction in both WT and KO podocytes 60
minutes after loading with albumin. �, p< 0.0001 compared to the same condition at t = 0; n = 8 experiments. Time (0, 60) is in minutes; L = leupeptin.
https://doi.org/10.1371/journal.pone.0209732.g002
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albumin [7, 10, 13, 28, 29]. Since podocyte specific KO of FcRn did not result in intraglomeru-
lar accumulation of albumin over time and KO mice demonstrated no increase in albuminuria
with age, we examined whether there were differences in the tubular accumulation of albumin
in control and podocyte specific FcRn KO animals. We found that at 3 months of age there
was minimal accumulation of albumin in the tubules of both control and podocyte-specific
FcRn KO mice. By 6 months of age, both control and KO mice had albumin accumulation
within some tubules which was further increased by 12 months of age (Fig 5).
Fig 3. Functional parameters in podocyte-specific FcRn knock-out mice. A, There were no differences in serum albumin or IgG levels between podocyte-specific FcRn
KO (FcRn fl/fl; Pod-Cre/+) and control (FcRn fl/fl;+/+) mice (n = 14 KO and n = 12 control mice). B, Podocyte-specific FcRn KO and control mice had minimal
albuminuria at 3 months and no significant increase in albuminuria with age (n = 3 control and 3 KO mice at 3 months, 6 KO and 6 control mice at 6 months and 6 KO
and 6 control mice at 12 months). C., There was no significant difference in GFR measurements in 9–12 month old control or podocyte-specific FcRn KO mice (n = 4
control and 3 KO mice).
https://doi.org/10.1371/journal.pone.0209732.g003
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Podocyte-specific KO of FcRn leads to increased mesangial:Glomerular
area ratio
By 6 months of age, podocyte-specific FcRn KO mice had a significant decrease in glomerular
area compared to control mice (1703 ± 62.7 μm2 2198 ± 92.9 μm2, p< 0.0001) and a significant
increase in the mesangial to glomerular area (0.41 ± 0.01 vs 0.27 ± 0.01, p< 0.0001; Fig 6A). By
Fig 4. Podocyte-specific FcRn KO resulted in a significant increase in intraglomerular IgG accumulation, but no change in albumin accumulation. A,
Intraglomerular IgG: At 3 months of age, there was no significant difference in IgG accumulation between podocyte specific FcRn KO (fl/fl; cre/+) and control mice (fl/fll;
+/+). (n = 3 mice per group). By 6 months of age there was a statistically significant increase in intraglomerular IgG accumulation in podocyte-specific FcRn KO (fl/fl;cre/
+) compared to controls (fl/fl;+/+) (n = 6 control and 6 KO mice, � p< 0.05). Intraglomerular IgG accumulation was even more significantly increased by 12 months of
age in the podocyte-specific FcRn KO (n = 6 control and 6 KO mice, �� p< 0.0001). Scale bar 20 μm. B, Intraglomerular Albumin: Albumin accumulation in control and
podocyte-specific FcRn KO mouse glomeruli was minimal and was not significantly different between control and KO animals at 3, 6 or 12 months. By 12 months of age,
both control and podocyte-specific FcRn KO mice had significantly less intraglomerular albumin than 3 month old control or KO animals, � p< 0.01, �� p< 0.0001. Scale
bar 20 μm. NS = not significant. Number of mice per group was the same as in A.
https://doi.org/10.1371/journal.pone.0209732.g004
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12 months of age, there was a further significant increase in the mesangial/glomerular area in
the podocyte-specific FcRn KO compared to controls (0.46 ± 0.01 vs 0.35 ± 0.01, p< 0.0001),
with a resultant increase in the glomerular area in the KO to close to that of control (Fig 6B). To
further examine the mesangial expansion seen in the podocyte-specific FcRn KO mice, we
examined the glomerular expression of α-smooth muscle actin (α-SMA), a marker of activated
mesangial cells [30]. We found an increase in glomerular α-SMA actin expression by 3 months
in podocyte-specific FcRn KO versus control which was statistically significant by 6 and 12
Fig 5. Albumin accumulates in control and podocyte-specific FcRn knockout mice with age. Albumin vesicles
(green) are not seen in control or podocyte-specific FcRn knockout at 3 months of age. By 6 months of age, albumin is
seen in tubules in both control and KO mice (arrows) with more prominent vesicles seen by 12 months in both control
and KO animals.
https://doi.org/10.1371/journal.pone.0209732.g005
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month months (α-SMA intensity/glomerular area for 3 month KO vs control 3.2 ± 0.3 vs
1.2 ± 0.1; for 6 month KO vs control 7.5 ± 0.5 vs 4.0 ± 0.3, p< 0.01; for 12 month KO versus
control 16.3 ± 1.0 vs 5.6 ± 0.3, p< 0.0001, Fig 7). While older podocyte specific FcRn KO mice
demonstrated mesangial expansion, there was no significant difference in eGFR in 9–12 month
control or KO mice (Fig 3C).
Discussion
Proteinuria is a common clinical marker of kidney damage and is strongly associated with pro-
gression of kidney disease [2, 31]. The mechanisms underlying renal handling of serum pro-
teins such as albumin and IgG remain to be fully elucidated. Human and animal studies have
shown podocyte vacuolization in proteinuric kidney diseases and albumin and IgG have been
shown to colocalize with podocyte vacuoles [5, 10, 32–37]. Previously, we have shown that cul-
tured podocytes endocytose albumin and that the majority of endocytosed albumin is transcy-
tosed. Here we extend our findings to an in vivo model and also examine podocyte handling of
IgG. To our knowledge, this is the first systematic concurrent examination of podocyte albu-
min and IgG trafficking in podocytes.
In renal proximal tubular cells, FcRn is required for salvaging albumin and IgG from the
degradative pathway and transcytosing these proteins from the apical cell surface to the baso-
lateral side [16]. Others have shown that injection of an anti-FcRn antibody reduces protein-
uria in nephrotic rats [34] and that global FcRn KO mice accumulate IgG within the
glomerulus by 6 months of age [20]. Our study, however, is the first to directly demonstrate
the role of FcRn in albumin and IgG handling in cell culture and in an in vivo model in which
Fig 6. Podocyte-specific FcRn KO resulted in mesangial expansion as mice aged. A, 6 month old podocyte-specific FcRn KO mice had a decrease in mean glomerular
area (��, p< 0.0001) and an increase in mesangial/glomerular area (��, p< 0.0001 compared to controls). Scale bar 20 μm. B, By 12 months of age, mean glomerular area
was similar in podocyte-specific FcRn KO and control mice but the podocyte-specific KO manifested a further increase in glomerular/mesangial area (��, p< 0.0001
compared to controls). Scale bar 20 μm.
https://doi.org/10.1371/journal.pone.0209732.g006
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only podocytes lack FcRn. Our studies demonstrate that albumin and IgG are differentially
handled by podocytes in vitro and in vivo. Lack of FcRn in cultured podocytes did not impair
albumin handling acutely. In vivo, lack of FcRn did not result in significant intraglomerular
accumulation of albumin. Interestingly, mice had significantly less intraglomerular albumin
accumulation at 12 months compared to 3 months in both podocyte-specific FcRn KO animals
and controls. Lack of intraglomerular albumin accumulation in podocyte-specific FcRn KO
mice was not due to technical issues with staining as albumin could be seen in the peritubular
and periglomerular capillaries.
Intravital imaging has provided evidence for passage of albumin through the glomerular fil-
tration barrier [7, 8, 29, 38], although the amount of albumin to transverse the GFB is widely
debated. Our study provides further evidence for passage of albumin through the GFB as both
Fig 7. Podocyte-specific FcRn KO resulted in increased glomerular expression of α-smooth muscle actin. Intraglomerular expression of α-smooth muscle actin (α-
SMA) was significantly increased in 6 month podocyte-specific FcRn KO (fl/fl;Cre/+) mice compared to controls (fl/fl;+/) (�, p< 0.01, n = 6 control and 6 KO mice). The
increase in α-SMA expression was even more pronounced by 12 months of age (��, p< 0.0001, n = 6 control and 6 KO mice). Scale bar: 20 μm.
https://doi.org/10.1371/journal.pone.0209732.g007
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unmanipulated control and podocyte-specific FcRn knockout mice demonstrate albumin
accumulation within renal tubules over time. The precise mechanisms for albumin handling
in podocytes remain to be fully determined. Gianesello et al. have shown that megalin, cubilin,
amionless and the ClCl-5 channel are involved in the uptake of low doses of albumin in cul-
tured human podocytes [12] and we have shown that albumin endocytosis in cultured podo-
cytes is also dependent on caveolin [13]. Schiessl et al. have shown that in vivo, angiotensin II
dependent passage of albumin through the glomerular filtration barrier is dependent on mega-
lin [39]. In addition, we have found that in cultured human podocytes, endocytosed albumin
is degraded primarily in the lysosome [25]. In the proximal tubule, FcRn is required to divert
endocytosed albumin from the lysosmal degradative pathway. In the present study, however,
we find that in vitro, FcRn is not required for albumin transcytosis through the podocyte nor
does lack of FcRn in vivo lead to intraglomerular accumulation of albumin. The lack of albu-
min accumulation in podocytes both in vivo and in vitro suggests that podocytes possess
another non-FcRn dependent pathway for handling any serum albumin that passes through
the GFB.
Knockout of FcRn in podocytes led acutely to intracellular accumulation of IgG in vitro
and accumulation of IgG in vivo which became significant by 6 months of age. Lack of FcRn,
however, did not completely abrogate IgG transcytosis in cultured podocytes as evidenced by
the fact that some IgG appeared in the supernatant in FcRn KO cells after loading podocytes
with IgG and incubating in IgG free solution, suggesting the existence of an additional non-
FcRn dependent pathway for IgG handling.
Akilesh et al. found increased IgG accumulation in the glomeruli of global FcRn KO mice
compared to wild type at 6 months of age [20]. There are several important differences
between our study and that of Akilesh et al. We used podocyte-specific FcRn KO mice which
have normal circulating levels of albumin and IgG whereas Akilesh et al. used global FcRn KO
mice which have serum albumin levels that are 50% lower and serum IgG levels that are 80–
90% lower than those of wild type animals. In addition, we performed systematic quantitation
of albumin and IgG staining in podocyte-specific FcRn KO mice or controls as mice aged
using confocal microscopy whereas Akilesh et al. used epifluorescence microscopy on wild
type or global FcRn KO mice at a single time point (6 months) and did not perform any
quantitation.
An interesting finding of the present study is that podocyte-specific knockout of FcRn leads
to mesangial expansion in the KO mice as they age as well as increased expression of α-smooth
muscle actin within the mesangial regions of the glomerulus, suggesting activation of mesan-
gial cells with intraglomerular IgG accumulation. Upregulation of a-smooth muscle actin has
been linked to progression of fibrosis [40], suggesting that dysregulated serum protein traffick-
ing in podocytes might contribute to CKD progression. The mechanisms underlying how
knockout of a trafficking protein in a podocyte can lead to an expansion of mesangial area and
increased expression of α-SMA remain to be further investigated.
In summary we have directly examined the role of FcRn in albumin and IgG trafficking in
poodcytes and found that FcRn-mediated trafficking of these proteins differs. Podocyte-spe-
cific FcRn knockout impairs glomerular handling of IgG whereas albumin handling is not
affected. Differences in intra podocyte trafficking of these proteins may reflect differences in
their biologic functions. Albumin often serves as a carrier for different molecules such as lipids
whereas IgG is a component of the immune system. Our findings suggest that intra-podocyte
trafficking pathways are complex and that disruption of normal trafficking pathways in podo-
cytes is deleterious.
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Supporting information
S1 Fig. Uncropped images for western blots in Fig 1C.
(TIF)
S2 Fig. Uncropped images for western blots in Fig 2A and 2B.
(TIF)
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